| No | Company | Methods and Characteristics of Circularization | Pipeline |
| 1 | Orna | Group l Intron System | Cancer (in vivo CART) |
| 2 | LARONDE | T4 Dnl/Rnl | Cancer |
| 3 | Therorna Inc | Group l lntron System | Vaccines |
| 4 | CureMed | T4 Group l lntron System (Clean-PIE) | Cancer |
| 5 | CirCode | Group ll Ilntron System | Vaccines |
| 6 | ExclCirc | TIE Self-Circularization System | Metabolism, Nerves,Tumors |
| 7 | Geneseed | T4 Rnl2 | CRO |

